PharmaShots | Incisive News in 3 Shots

Subscribe Now

stelara

Top 20 BioPharma Companies based on 2022 Total Revenue

Top 20 BioPharma Companies based on 2022 Total Revenue

April 12, 2023

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value

March 29, 2023

PharmaShots Interview: Janssen's Andrew Greenspan Shares Insight About the New AGA Guidelines Recommending Stelara (Ustekinumab) as a First-Line Treatment Option in Crohn's Disease

PharmaShots Interview: Janssen's Andrew Greenspan Shares Insight About the New AGA Guidelines Recommending Stelara (Ustekinumab) a...

August 17, 2021

PharmaShots Interview: Janssen's Jan Wehkamp Shares Insight on the Data from UNIFI Study of Stelara Presented at ECCO

PharmaShots Interview: Janssen's Jan Wehkamp Shares Insight on the Data from UNIFI Study of Stelara Presented at ECCO

August 9, 2021

Bio-Thera Reports First Patient Dosing in P-III Study for BAT2206 Proposed Biosimilar of Stelara (ustekinumab)

Bio-Thera Reports First Patient Dosing in P-III Study for BAT2206 Proposed Biosimilar of Stelara (ustekinumab)

July 16, 2021

Janssen Presents Three-Year Data of Stelara (ustekinumab) in P-lll UNIFI LTE Study for the Treatment of Moderately to Severely Active Ulcerative Colitis at ECCO

Janssen Presents Three-Year Data of Stelara (ustekinumab) in P-lll UNIFI LTE Study for the Treatment of Moderately to Severely Act...

July 12, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us